![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2018
Camidge, D. Ross; Kim, Dong-Wan; Tiseo, Marcello; Langer, Corey J.; Ahn, Myung-Ju; Shaw, Alice T.; Huber, Rudolf M.; Hochmair, Maximilian J.; Lee, Dae Ho; Bazhenova, Lyudmila A.; Gold, Kathryn A.; Ou, Sai-Hong Ignatius; West, Howard L.; Reichmann, William; Haney, Jeff; Clackson, Tim; Kerstein, David und Gettinger, Scott N.
(2018):
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.
In: Journal of Clinical Oncology, Bd. 36, Nr. 26: S. 2693-2701
2017
Kim, Dong-Wan; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen L.; Hansen, Karin Holmskov; Kim, Sang-We; Huber, Rudolf M.; West, Howard L.; Grön, Harry J. M.; Hochmair, Maximilian J.; Leighl, Natasha B.; Gettinger, Scott N.; Langer, Corey J.; Rodriguez, Luis G. Paz-Ares; Smit, Egbert F.; Kim, Edward S.; Reichmann, William; Haluska, Frank G.; Kerstein, David und Camidge, D. Ross
(2017):
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.
In: Journal of Clinical Oncology, Bd. 35, Nr. 22: S. 2490-2500
Camidge, D. Ross; Tiseo, Marcello; Ahn, Myung-Ju; Reckamp, Karen; Hansen, Karin; Kim, Sang-We; Huber, Rudolf; West, Howard; Grön, Harry; Hochmair, Maximilian; Leighl, Natasha; Gettinger, Scott; Langer, Corey; Paz-Ares, Luis; Smit, Egbert; Kim, Edward; Reichmann, William; Clackson, Tim; Kerstein, David; Haluska, Frank und Kim, Dong-Wan
(2017):
Brigatinib in Crizotinib-Refractory ALK plus NSCLC: Central Assessment and Updates from ALTA, a Pivotal Randomized Phase 2 Trial.
In: Journal of thoracic Oncology, Bd. 12, Nr. 1:
S1167-S1169
Gettinger, Scott; Kim, Dong-Wan; Tiseo, Marcello; Langer, Corey; Ahn, Myung-Ju; Shaw, Alice; Huber, Rudolf; Hochmair, Maximilian; Kim, Sang-We; Bazhenova, Lyudmila; Gold, Kathryn; Ou, Sai-Hong; West, Howard; Reichmann, William; Haney, Jeff; Clackson, Tim; Haluska, Frank; Kerstein, David und Camidge, D. Ross
(2017):
Brigatinib Activity in Patients with ALK plus NSCLC and Intracranial CNS Metastases in Two Clinical Trials.
In: Journal of thoracic Oncology, Bd. 12, Nr. 1:
S273-S274